Stephen Fortmann to Case-Control Studies
This is a "connection" page, showing publications Stephen Fortmann has written about Case-Control Studies.
Connection Strength
0.581
-
The Health and economic effects of light rail lines: design, methods, and protocol for a natural experiment. BMC Public Health. 2019 Feb 15; 19(1):200.
Score: 0.132
-
The association between different A1C-based measures of glycemia and risk of cardiovascular disease hospitalization. Diabetes Care. 2014; 37(1):167-72.
Score: 0.090
-
Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts? J Am Coll Cardiol. 2006 Nov 07; 48(9):1800-7.
Score: 0.056
-
Validation of a new brief physical activity survey among men and women aged 60-69 years. Am J Epidemiol. 2006 Sep 15; 164(6):598-606.
Score: 0.055
-
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group. Circulation. 2004 Dec 21; 110(25):e554-9.
Score: 0.049
-
Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis Throughout the Life-Course. Circ Cardiovasc Genet. 2015 Dec; 8(6):803-11.
Score: 0.026
-
Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J Am Coll Cardiol. 2011 Oct 04; 58(15):1600-7.
Score: 0.020
-
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol. 2010 Nov 02; 56(19):1552-63.
Score: 0.019
-
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet. 2008 Aug 01; 17(15):2320-8.
Score: 0.016
-
Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD. BMC Med Genet. 2008 Apr 02; 9:23.
Score: 0.015
-
Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet. 2008 May; 123(4):399-408.
Score: 0.015
-
Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease. Am Heart J. 2007 Dec; 154(6):1043-51.
Score: 0.015
-
Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Am Heart J. 2007 Dec; 154(6):1059-64.
Score: 0.015
-
Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J. 2007 Dec; 154(6):1035-42.
Score: 0.015
-
Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics. 2007 Nov 14; 31(3):402-9.
Score: 0.015
-
Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med. 2006 Feb 21; 144(4):229-38.
Score: 0.013
-
A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler Thromb Vasc Biol. 1997 Feb; 17(2):239-45.
Score: 0.007
-
Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996 Sep 18; 276(11):875-81.
Score: 0.007